Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 14 Breast Neoplasms 11 Polycystic Ovary Syndrome 8 Obesity 8 Colorectal Neoplasms 8 Weight Loss 6 Neoplasms 6 Prostatic Neoplasms 5 Colonic Neoplasms 5 Endometrial Neoplasms 4 Multiple Endocrine Neoplasia Type 1 3 Recurrence 2 Pancreatic Neoplasms 2 Overweight 2 Ovarian Neoplasms 2 Malnutrition 2 Lymphoma, Follicular 2 Lymphoma 2 Lung Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Body Weight Changes 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Smoking 1 Sexual Dysfunction, Physiological 1

Interventions

Temozolomide 405 Radiotherapy 202 Bevacizumab 157 Radiation 80 Magnetic Resonance Spectroscopy 77 Lomustine 49 Surgical Procedures, Operative 45 Carmustine 41 pembrolizumab 40 Irinotecan 38 Nivolumab 32 Specimen Handling 28 Carboplatin 27 Radiosurgery 24 Erlotinib Hydrochloride 24 Drug Therapy 23 Chemotherapy, Adjuvant 23 Radiotherapy, Intensity-Modulated 22 Cyclophosphamide 20 Aminolevulinic Acid 20 O(6)-benzylguanine 17 sargramostim 16 Radiotherapy, Conformal 15 Blood Specimen Collection 15 temsirolimus 14 Granulocyte-Macrophage Colony-Stimulating Factor 14 Everolimus 14 Vorinostat 13 Sorafenib 13 Ipilimumab 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Glioblastoma × Diet × Clear all

NCT07553520 2026-04-28

Dietary Cysteine and Methionine Deprivation (CMD) in Glioma Patients

UNC Lineberger Comprehensive Cancer Center

Phase NA Withdrawn

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡